Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.

Source:http://linkedlifedata.com/resource/pubmed/id/12573054

Hum. Gene Ther. 2003 Jan 1 14 1 1-12

Download in:

View as

Triples

General Info

PMID
12573054